JW Group Joins Hands with U.S. Venture Capital to Promote Open Innovation

By • on July 14, 2022

The Business Korea website reported that the JW Group has signed a business agreement with ARCH Venture Partners, a U.S. venture capital to promote open innovation with global biotech companies. This is the first time that a Korean pharmaceutical company has joined hands with a biotech and healthcare venture capital firm in the United States to promote open innovation in basic research. JW Group is planning to expand its open innovation partners to global biotech giants by utilizing the ARCH Technical Service, which provides technical information of promising biotech companies to strategic investors interested in business cooperation with venture companies.

Click here to read the full article.

Image via Flickr.

Related Posts

Related Entries

Recent Entries

Purchase viagra online and purchase it from the good to cope with dependable and trustworthy pharmacy. Don't believe of the recommendation by a mantra but instead as suggestion that is useful since that might be really a correct move to make to think about. It's not just about general ease of doing all of your buying resting before your Computer, or around no prerequisite to depart your home or stand-in point, but additionally concerning the choices you might have barely considered overall. Visit the drugstore you might have handled earlier in the event that you know the thing you need precisely. Examine the options what, why and just how if, nevertheless, you will find neither particular needs or a drugstore to go to.